Category: Healthcare and Pharmaceuticals - Page 3

Explore various alternatives to Drugwatch.com for reliable drug information and health resources. These platforms offer a mix of medical guidelines, patient leaflets, and practical advice tailored to different geographical contexts. Understand the pros and cons of each option to find the one that best suits your needs.

In a significant move for asthma and COPD patients, AstraZeneca will cap the cost of its inhalers at $35 per month starting from June 2024. This decision, mirroring a rival's earlier action, aims to improve affordability amidst legislative scrutiny and allegations of anti-competitive practices.